DIGE Digene Corp (MM)

GAITHERSBURG, Md., June 1 /PRNewswire-FirstCall/ -- Digene Corporation (NASDAQ:DIGE), today announced that the Company will webcast audio from presentations at the Company's Investment Community Day on Tuesday, June 5, 2007. The event will be held from 8:30 a.m. to 12:30 p.m. EDT. The event will feature presentations from Digene's senior management team, as well as guest speakers from Columbia University and University Hospital Vrije Universiteit, Amsterdam, The Netherlands. The Analyst and Investor Day will be webcast live and may be accessed through a link on Digene's website at http://www.digene.com/. An archive of the presentation will be available on Digene's website until August 5, 2007. About Digene A leader in molecular diagnostics, Digene develops, manufactures and markets proprietary DNA and RNA tests, with a focus on women's health. The company's flagship product, the Digene(R) HPV Test, is the only FDA-approved and CE-marked test for the detection of human papillomavirus, the cause of essentially all cervical cancers. Digene's product portfolio also includes tests for the detection of other sexually transmitted infections, including chlamydia and gonorrhea. Digene tests are marketed in more than 40 countries worldwide. Headquartered in Gaithersburg, MD, Digene is traded on NASDAQ under the symbol DIGE. For more information, visit http://www.digene.com/ and http://www.thehpvtest.com/. Digene(R), Hybrid Capture(R), hc2 High-Risk HPV DNA Test(R) and DNAwithPap(R) are registered trademarks of Digene Corporation. DATASOURCE: Digene Corporation CONTACT: Albert Fleury, +1-301-944-7000, or Media, Pam Rasmussen, +1-301-944-7196, both of Digene Corporation Web site: http://www.digene.com/ http://www.thehpvtest.com/

Copyright